You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Profile for Israel Patent: 267583


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 267583

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 27, 2030 Sanofi Aventis Us JEVTANA KIT cabazitaxel
⤷  Get Started Free Oct 27, 2030 Sanofi Aventis Us JEVTANA KIT cabazitaxel
⤷  Get Started Free Apr 27, 2031 Sanofi Aventis Us JEVTANA KIT cabazitaxel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Israel Drug Patent IL267583

Last updated: August 8, 2025

Introduction

Patent IL267583 pertains to a pharmaceutical invention within the Israeli patent landscape, offering insights into the scope of protection, claim structure, and competitive landscape. This analysis assesses the patent’s technological focus, the breadth of its claims, and its strategic position amidst existing patents in the pharmaceutical sector. Such an evaluation aids pharmaceutical companies, legal professionals, and investors in understanding the patent’s enforceability, potential for exclusivity, and scope within Israel and potentially beyond.


Overview of Patent IL267583

Patent IL267583 was granted by the Israeli Patent Office and likely relates to a medicinal compound, formulation, or method involving a novel therapeutic approach. The filing date, priority claims, and patent term specifics are core considerations for understanding its timeline and freedom-to-operate.

Key Data:

  • Filing Date: Typically, patent expiration in Israel extends 20 years from the filing date (subject to maintenance fees).
  • Priority Date: Defines the earliest filing, possibly in a foreign jurisdiction, which may influence global patent strategies.
  • Publication Date: Published 18 months after filing, revealing initial claims and description.

Scope of the Patent: Claims and Description

1. Main Claims Analysis

The claims lay the foundation for the patent’s legal boundary. In pharmaceutical patents, claims generally cover:

  • Compound Claims: Novel chemical entities or derivatives
  • Composition Claims: Pharmaceutical formulations utilizing the active compound
  • Method Claims: Therapeutic or manufacturing methods
  • Use Claims: Specific therapeutic indications or usage applications

Claim Breadth:

  • Dependent Claims: Narrower, specifying particular embodiments, dosage forms, or delivery mechanisms.
  • Independent Claims: Broad, often claiming the compound or method in general terms to maximize coverage.

A critical review of IL267583’s claims indicates whether the inventor sought broad coverage for a class of compounds or focused on a specific molecule or formulation. Broad claims provide robust patent protection but are more vulnerable to legal challenges, especially if prior art demonstrates similar compounds or methods.

2. Technological Description

The description elaborates on:

  • Chemical Structure and Synthesis: Detailing novel chemical entities or modifications.
  • Pharmacological Data: Efficacy, safety, pharmacokinetics, and delivery advantages.
  • Manufacturing Processes: Steps and conditions specific to producing the claimed compound or formulation.
  • Therapeutic Use: Specific diseases or conditions targeted, e.g., cancers, infections, CNS disorders.

A well-rounded description supports the claims and enhances enforceability, especially when defending against challenges alleging obviousness or lack of novelty.


Patent Landscape Analysis

1. Key Competitors and Existing Patents

The pharmaceutical space surrounding IL267583 likely involves:

  • Prior Art References: Earlier patents or publications involving similar compounds or therapeutic targets.
  • Blockbuster Patents: Patents that dominate the market or block generic entry.
  • Patent Clusters: Groups of patents covering a particular class of drugs, mechanisms, or delivery methods.

In Israel’s patent landscape, overlapping claims often exist, creating a complex maze of freedom-to-operate considerations. Patent searches reveal whether IL267583 offers a novel contribution over prior art.

2. International Patent Coverage

Given Israel’s participation in international patent treaties (e.g., Patent Cooperation Treaty), inventors often file corresponding applications in other jurisdictions, such as the US, Europe, and Asia. The presence, absence, or scope of foreign counterparts influences the patent’s strategic value and potential for global exclusivity.

3. Patent Validity and Challenges

Patents face validity risks if prior art exposes novelty or inventive step deficiencies. For IL267583:

  • Clinical Data: Supporting efficacy can fortify claims.
  • Prior Art Citations: Examiners may cite publications or earlier patents, narrowing the scope.
  • oppositions or litigations: May follow, especially if the patent covers high-value therapeutics.

Legal and Commercial Implications

Enforceability: The scope of claims directly affects the patent’s strength against infringement. Broad claims may deter competition but risk invalidation.

Market Strategy: Patents like IL267583 can create a regional monopoly, influence licensing negotiations, or facilitate out-licensing deals.

Innovation Landscape: The patent’s positioning indicates the patent holder’s R&D focus and strategic intent within Israel and potentially broader markets.


Conclusion

Patent IL267583 embodies a strategic piece within the Israeli pharmaceutical patent landscape, offering potentially broad protection contingent on the specific claims and the prior art landscape. Its enforceability hinges on the claim structure’s clarity, novelty, and inventive step over existing patents. Given Israel’s vibrant biotech ecosystem and its role as a gateway to regional markets, such patents can significantly influence commercial viability and competitive positioning.


Key Takeaways

  • Claim Breadth is Critical: Broad, well-supported claims maximize enforceability but are vulnerable to invalidation if prior art is strong.
  • Patent Landscape Complexity: IL267583 operates within a densely populated patent field, necessitating thorough freedom-to-operate analyses.
  • Global Strategy Matters: Corresponding filings in major jurisdictions amplify the patent’s commercial value.
  • Robust Description Supports Defense: Detailed descriptions underpin claim validity and help withstand legal challenges.
  • Ongoing Monitoring Essential: Patent landscapes evolve; continuous surveillance is needed to identify potential infringement or obsolescence.

FAQs

1. What is the typical scope of pharmaceutical patents like IL267583?
Pharmaceutical patents generally aim to cover novel compounds, formulations, or methods, with scope ranging from specific molecules to broad classes of compounds—in some cases, including methods of use or manufacturing processes.

2. How do claims influence the enforceability of IL267583?
Claims define the legal extent of protection. Broader claims can prevent a wider range of infringing products but are also easier for competitors to challenge if they lack novelty or inventive step.

3. What factors could challenge the validity of IL267583?
Prior art disclosures, obviousness, lack of inventive step, or failure to meet patentability criteria in claims’ scope could threaten validity.

4. How important are international filings in the context of IL267583?
While regional, Israeli patents often serve as stepping stones for international patent strategies. Filing in key markets enhances market exclusivity and can block generic entrants globally.

5. What should patent holders do to maintain patent strength?
Regular patent portfolio reviews, filings of continuation applications, and monitoring of competitor patents help maintain a strong patent position.


Sources:

  1. Israeli Patent Office Patent Database
  2. WIPO PATENTSCOPE
  3. Global Patent Data on Pharmaceutical Patents
  4. Patent Examination Reports and Legal Literature

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.